ArticleFrontiers in pharmacology2024

Case report: Treatment with ensartinib shows good response to SQSTM1-ALK fusion in lung adenocarcinoma.

Pandeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.